Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Matthew Walls Insider Profile
4 Followers
Matthew Walls, Chief Executive Officer at Genedrive, holds 12.24M shares in GENinCode UK Ltd. (Ticker: GB:GENI), holds 1.52M shares in MyHealthChecked PLC (Ticker: GB:MHC), holds 13.77K shares in Genedrive (Ticker: GB:GDR). Most recently, Matthew Walls Bought ― shares of GENinCode UK Ltd. on Feb 14, 2025 for an estimated value of 17.50K.
Matthew Walls Genedrive (GDR)Chief Executive Officer
Genedrive (GDR)
Chief Executive Officer
Ranked #89,871 out of 100,516 Corporate Insiders
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-42.10%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Matthew Walls holds in companies
Most Profitable Insider Trade
The most profitable trade made by Matthew Walls
Matthew Walls's Trading History
Genedrive
Oct 15, 2015
Chief Executive Officer
Uninformative Buy
2.36K
£275.42
MyHealthChecked PLC
Apr 08, 2019
Director
Informative Buy
30.00K
£274.50K
GENinCode UK Ltd.
Feb 14, 2025
Chief Executive Officer
Informative Buy
17.50K
£434.36K
List of latest transactions for each holding click on a transaction to see Matthew Walls's performance on stock
You May Also Like
Matthew Walls insider profile FAQ
What is the percentage of profitable transactions made by Matthew Walls?
The percentage of profitable transactions made by Matthew Walls is 0%.
What is the average return per transaction made by Matthew Walls?
The average return per transaction made by Matthew Walls is -42.10%.
What stocks does Matthew Walls hold?
Matthew Walls holds: GB:GDR, GB:MHC, GB:GENI stocks.
What was Matthew Walls’s latest transaction?
Matthew Walls latest transaction was an Informative Buy of 17.50K.
What was Matthew Walls's most profitable transaction?
Matthew Walls’s most profitable transaction was an Informative Buy of GB:GENI stock on December 22, 2023. The return on the trade was -27.60%.
What is Matthew Walls's role in Genedrive?
Matthew Walls's role in Genedrive is Chief Executive Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.